Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Predominant Autoantibody Production by Early Human B Cell Precursors
2003 StandoutScience
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein
2000 StandoutNobel
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
1988 StandoutScience
Redox Regulation of NF-kappa B Activation
1997
Distinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus
1999
Human leukocyte IgG Fc receptors
1986
Role of redox potential and reactive oxygen species in stress signaling
1999
Truncated Thioredoxin Is a Mitogenic Cytokine for Resting Human Peripheral Blood Mononuclear Cells and Is Present in Human Plasma
2000
A Novel Promoter Sequence Is Involved in the Oxidative Stress-Induced Expression of the Adult T-Cell Leukemia-Derived Factor (ADF)/Human Thioredoxin (Trx) Gene
1996
Distinct effects of glutathione disulphide on the nuclear transcription factors κB and the activator protein‐1
1994
Oxidative stress and gene regulation
2000
Lens-Specific Regulation of the Thioredoxin-1 Gene, but Not Thioredoxin-2, upon in Vivo Photochemical Oxidative Stress in the Emory Mouse
1999
Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes
2001
Structure of Antibody-Antigen Complexes: Implications for Immune Recognition
1988
Gene expression and the thiol redox state
1999
Short synthetic glycopeptides successfully induce antibody responses to carcinoma‐associated Tn antigen
2000
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
1999 StandoutNatureNobel
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Hydrogen peroxide as a potent activator of T lymphocyte functions
1995
Human T-cell receptor variable gene segment families
1995
Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase
1997
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
1993 StandoutNature
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Alpha-lipoic acid as a biological antioxidant
1995 Standout
Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding
2020
Human antibody–Fc receptor interactions illuminated by crystal structures
2004
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage
1991 StandoutNobel
Physiological functions of thioredoxin and thioredoxin reductase
2000 Standout
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
1998
Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex
2001
Clonal selection and learning in the antibody system
1996 StandoutNature
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.
2001 Standout
Redox signaling in macrophages
2001
Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide.
1995
1-Chloro-2,4-dinitrobenzene Is an Irreversible Inhibitor of Human Thioredoxin Reductase
1995
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 StandoutNatureNobel
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The binding site for C1q on IgG
1988 StandoutNatureNobel
Open sandwich ELISA: A novel immunoassay based on the interchain interaction of antibody variable region
1996 StandoutNobel
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit
1996
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The p66shc adaptor protein controls oxidative stress response and life span in mammals
1999 StandoutNature
Oxidative Stress in Severe Pulmonary Hypertension
2004
Polymerase Chain Reaction with Single-Sided Specificity: Analysis of T Cell Receptor δ Chain
1989 Science
Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors
1981
Structure and polymorphism of the mouse prion protein gene.
1994 StandoutNobel
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
rac1 Regulates a Cytokine-Stimulated, Redox-Dependent Pathway Necessary for NF-κB Activation
1996
The Staphylococcal Enterotoxins and Their Relatives
1990 StandoutScience
The Predicted Structure of Immunoglobulin D1.3 and Its Comparison with the Crystal Structure
1986 StandoutScienceNobel
Molecular anatomy of the antibody binding site.
1983
Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents.
1996
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
1991 StandoutNobel
Receptor editing: an approach by autoreactive B cells to escape tolerance.
1993
Immunoglobulin G: Functional sites
1985
Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis
1995 StandoutScience
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.
1989
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
1998 StandoutScience
Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
2000 StandoutNobel
Activation of the NF-κB transcription factor in a T-lymphocytic cell line by hypochlorous acid
1997
Limited diversity of the rearranged T-cell γ gene
1985 StandoutNatureNobel
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
1995
AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1
1997
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region.
1981
Nitrosation and oxidation in the regulation of gene expression
2000
The outline structure of the T-cell alpha beta receptor.
1988
NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
1998 StandoutScience
The use of anti-IgG monoclonal antibodies in mapping the monocyte receptor site on IgG
1986
Repression of gene expression by oxidative stress
1999
The NMR–Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope
2015 StandoutNobel
Rho GTPases and the Actin Cytoskeleton
1998 StandoutScience
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
1995 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
1994 StandoutNobel
Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription
1997 StandoutNobel
The Mononuclear Molybdenum Enzymes
1996 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines
1994
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin.
1987
Multifactorial Nature of Human Immunodeficiency Virus Disease: Implications for Therapy
1993 Science
The Mononuclear Molybdenum Enzymes
2014 Standout
Human T-cell-receptor delta chain: genomic organization, diversity, and expression in populations of cells.
1988
Antioxidant and redox regulation of gene transcription
1996 Standout
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.
1994
IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase.
1995
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
1996
Enhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool
2000
Presentation of a Viral T Cell Epitope Expressed in the CDR3 Region of a Self Immunoglobulin Molecule
1993 StandoutScienceNobel
The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains
1984 StandoutNatureNobel
Free Radicals in the Physiological Control of Cell Function
2002 Standout
REGULATION OF GENE EXPRESSION BY REACTIVE OXYGEN
1999
Secondary, tertiary, and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains.
1986 StandoutNobel
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
1987
Review article: Fcγ receptors in the human placenta
1981
Dynamical Mapping of E. coli Thioredoxin via 13C NMR Relaxation Analysis
1996
Diversity at the variable-joining region boundary of lambda light chains has a pronounced effect on immunoglobulin ligand-binding activity.
1984
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Works of M. Klein being referenced
Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL.
1982
Sequences of the genes encoding the A, B and C subunits of the Haemophilus influenzae dimethylsulfoxide reductase complex
1996
Distinct effects of thioredoxin and antioxidants onthe activation of transcription factors NF-kappa B and AP-1.
1994
The interaction of murine IgG subclass proteins with human monocyte Fc receptors.
1985
Diversity and structure of human T-cell receptor alpha-chain variable region genes.
1987
The Fc gamma receptor on human placental plasma membrane. I. Studies on the binding of homologous and heterologous immunoglobulin G1.
1980
A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
1997
Cyclosporine-induced deterioration in patients with AIDS.
1989
Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies.
1991
Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine
1992